Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia

Vaccine

Volumn 14, Issue 15, 1996, Pages 1466-1470

  Valero, M V ^a   Amador, R ^a   Aponte, J J ^a   Narvaez, A ^a   Galindo, C ^a   Silva, Y ^a   Rosas, J ^a   Guzman, F ^a   Patarroyo, M E ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Field trial; Malaria vaccine; Plasmodium falciparum; SPf66 vaccine

Indexed keywords

MALARIA VACCINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; COLOMBIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALARIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLOMBIA; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE; MIDDLE AGED;

EID: 0030458750     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00070-9     Document Type: Article

References (20)

1. 1 Patarroyo, M.E., Amador, R., Clavijo, P. et al. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 1988, 332, 158-161
2. 2 Moreno, A. and Patarroyo, M.E. Development of an asexual blood stage malaria vaccine. Blood 1989, 74, 537-546
3. 3 Valero, M.V., Amador, R., Galindo, C. et al. Vaccination with Spf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 1993, 341, 705-710
4. 4 Sempertegui, F., Estrella, B., Moscoso, F. et al. Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled trial in an endemic area of Ecuador. Vaccine 1994, 12, 337-342
5. 5 Noya, O., Gabaldon, I., de Noya, B. et al. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela. J. Infect. Dis. 1994, 170, 396-402
6. 6 Alonso, P.L., Smith, T., Armstrong Schellenberg, J.R.M., Masanja, H., Mwankusye, S., Urassa, H. et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1994, 344, 1175-1181
7. 7 Quiñonez, M., Suarez, M. and Fleming, G. Distribución y binomia de los anofelinos de la costa pacifica de Colombia. Colombia Med. 1987, 18, 19-22
8. 8 Merrifield, R.B. Solid phase peptide synthesis. I Synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963, 85, 2149-2154
9. 9 Houghten, R. General method for the rapid solid phase synthesis of large numbers of peptides: specificity of antigen antibody interaction at the level of individual aminoacids. Proc. natn Acad. Sci. USA 1985, 82, 5131-5135
10. 10 Lopez, M.C., Silva, Y., Thomas, M.C. et al. Characterization of SPf(66)n: a chimeric molecule used as a malaria vaccine. Vaccine 1994, 12, 585-591
11. 11 Salcedo, M., Barreto, L., Rojas, M., Moya, R., Cote, J. and Patarroyo, M.E. Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria. Clin. Exp. Immun. 1991, 84, 122-128
12. 12 Collect, D. Modelling Survival Data in Medical Research. Chapman and Hall, London, 1994
13. 13 Patarroyo, G., Franco, L., Amador, R. et al. Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1-14 years. Vaccine 1992, 10, 175-178
14. 14 Amador, R., Moreno, A., Valero, V. et al. The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity. Vaccine 1992, 10, 179-184
15. 15 Amador, R., Moreno, A., Murillo, L.A. et al. Safety and Immunogenicity of the synthetic malaria vaccine Spf66 in a large field trial. J. Infect. Dis. 1992, 166, 139-144
16. 16 Teuscher, T., Armstrong Schellenberg, J.R.M., de Azevedo, I.B. et al. Spf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission. Vaccine 1994, 12, 328-336
17. 17 Tanner, M., Teuscher, T. and Alonso, P.L. SPf66 - the first malaria vaccine. Parasit. Today 1995, 11, 10-13
18. 18 Armstrong-Schellenberg, J., Smith, T., Alonso, P. and Hayes, R. What is clinical malaria? Finding case definitions for field research in highly endemic areas. Parasit. Today 1994, 10, 439-442
19. 19 D'Alessandro, U., Leach, A., Drakeley, C. et al. Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet 1995, 346, 462-467
20. 20 World Health Organization. Twelfth Programme Report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Vol. 12. World Health Organization, Geneva, 1995, pp. 64-76